is retatrutide a triple agonist hormone receptor for metabolic dysfunction-associated steatotic liver disease: randomized phase 2a trial Retatrutide, an investigational triple hormone
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25





























